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Mutations in TCF4, Encoding a Class I Basic Helix-Loop-Helix
Transcription Factor, Are Responsible for Pitt-Hopkins Syndrome,
a Severe Epileptic Encephalopathy Associated with Autonomic
Dysfunction
Jeanne Amiel, Marle`ne Rio, Loı¨c de Pontual, Richard Redon, Vale´rie Malan, Nathalie Boddaert,
Perrine Plouin, Nigel P. Carter, Stanislas Lyonnet, Arnold Munnich, and Laurence Colleaux
Pitt-Hopkins syndrome (PHS) is a rare syndromic encephalopathy characterized by daily bouts of hyperventilation and
a facial gestalt. We report a 1.8-Mb de novo microdeletion on chromosome 18q21.1, identiﬁed by array–comparative
genomic hybridization in one patient with PHS.We subsequently identiﬁed twodenovo heterozygousmissensemutations
of a conserved amino acid in the basic region of the TCF4 gene in three additional subjects with PHS. These ﬁndings
demonstrate that TCF4 anomalies are responsible for PHS and provide the ﬁrst evidence of a human disorder related to
class I basic helix-loop-helix transcription-factor defects (also known as “E proteins”). Moreover, our data may shed new
light on the normal processes underlying autonomic nervous system development and maintenance of an appropriate
ventilatory neuronal circuitry.
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Pitt-Hopkins syndrome (PHS) was originally described in
1978 in two unrelated patients with mental retardation,
recurrent episodes of hyperventilation, and a widemouth.1
Six additional cases have been reported subsequently, al-
lowing further clinical delineation of the syndrome.2–5 PHS
is deﬁned by severe psychomotor delay, epilepsy, and daily
bouts of diurnal hyperventilation starting in infancy;mild
postnatal growth retardation; postnatal microcephaly; and
distinctive facial features. Since most hitherto reported
cases have been sporadic, with males and females equally
affected, PHS is regarded as an autosomal dominant con-
dition with de novo mutations in index cases. We ascer-
tained four cases of PHS and performed a systematic 1-
Mb–resolution genomewide BAC-array screening for mi-
crodeletions or duplications in all subjects. Using this ap-
proach, we identiﬁed a 1.8-Mb de novo microdeletion on
chromosome 18q21.1 in one of the four subjects. Further
sequence analyses of the genes located within this interval
revealed causative de novo mutations in the TCF4 gene
(MIM 602272; GenBank accession number NM_003199)
in three further subjects with PHS. TCF4, a member of the
ubiquitous E-protein family, is therefore responsible for a
severe CNS and autonomous nervous system dysfunction
when mutated in humans.
A total of four patients were included in the study. In-
clusion criteria were (i) severe psychomotor delay, (ii)
moderate postnatal growth retardation andmicrocephaly,
and (iii) a PHS facial gestalt (ﬁg. 1). Indeed, facial features
consistently included enophthalmia, strabismus, and thin
eyebrows in their midline portion; a large nose with high
bridge and ﬂared nostril; a protruding philtrum;M-shaped
Cupid’s bow; ﬂeshy lips and wide mouth with shallow
and broad palate; and widely spaced teeth. The helices of
the ears were dysplastic and thick. The traits coarsened
with age, and the lower face got more protruding. All pa-
tients were born at term to unrelated parents after un-
eventful pregnancies (but subject 4 had nuchal edema),
with normal birth parameters and unremarkable medical
family history (table 1). Psychomotor delay was severe: no
patients sat unaided until age 13–18 mo, none walked
unassisted, and language was absent or limited to a few
single words. All but the youngest one developed seizures
and/or stereotypic movements of hands (clapping and
washing, but with persistent voluntary use of hands) and
head (rolling movements of the head) and daily episodes
of hyperventilation, which is the hallmark of the syn-
drome. These episodes started abruptly, lasted several min-
utes, and were followed by apnea, cyanosis, and occa-
sional loss of consciousness. These events happened dur-
ing wakefulness only and were not associated with epi-
leptic changes but were increased by emotions and fatigue.
Hypoxia was severe and frequent enough to generate club-
bing of ﬁngers in the oldest of our patients. Other features
included small penis and cryptorchidism, severe consti-
pation, gastroesophageal reﬂux, small hands with slender
ﬁngers and single palmar crease (SPC), and small feet with
pes planus. No congenital malformation was reported ex-
cept for a unilateral supernumerary nipple in two subjects.
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Figure 1. Frontal and proﬁle views of patients 1–4 with PHS,
with ages given in years (y). The consistent facial features asso-
ciate enophthalmia, strabismus, and thin eyebrows in their midline
portion; a large nose with high bridge and ﬂared nostril; a pro-
truding philtrum; M-shaped Cupid’s bow; ﬂeshy lips, wide mouth
with shallow and broad palate, and widely spaced teeth. The hel-
ices of the ears are dysplastic and thick. The traits coarsen with
age, and the lower face gets more protruding.
All were usually placid and happy, although one patient
experienced daily episodes of agitation and shouting, and
another had a sleep disorder with difﬁculty falling asleep.
He is currently receiving treatment of melatonin. One pa-
tient had mild thoracic scoliosis; none were spastic. Fi-
nally, dilated pupils with sluggish response to light were
noted in three patients.
Electroencephalogram (EEG) was recorded for all sub-
jects. No speciﬁc pattern was found in the two younger
patients (subjects 1 and 4), but occipital or central delta
waves unusual for that age were seen. In the older patients
(subjects 2 and 3), pseudoperiodic complexes were present
during wakefulness, on central or occipital regions, mixed
with spikes and slow spikes and waves. This pattern was
observed before the onset of epilepsy in subject 3. Mag-
netic resonance imaging (MRI) of the brain was available
for three patients and consistently showed a thin corpus
callosum,marked white-matter hyperintensity in the tem-
poral poles, small hippocampi, and moderate hypoplasia
of the frontal lobes (ﬁg. 2).
We analyzed the four patients by comparative genomic
hybridization (CGH) on a microarray developed by the
Wellcome Trust Sanger Institute and composed of 3,523
large insert clones ranging in size from 80 to 240 kb and
spread over the entire genome, with a mean resolution of
1 clone permegabase.6 An abnormal pattern involvingone
single clone was suggestive of an 18q21.1 monosomy in
patient 1 (1.8 Mb) (ﬁg. 3A). With use of clone RP11-
397A16 as a probe, FISH analyses on metaphase nuclei
from blood lymphocytes of the proband and her parents
conﬁrmed our array-CGH ﬁndings and showed that the
deletion had occurred de novo (not shown). Further ge-
notyping analysis with use of microsatellite DNA markers
showed irregular inheritance of markers D18S1119 and
D18S1127, with a single maternal contribution. FISH anal-
yses with use of probe RP11-397A16 failed to detect anom-
alies of chromosome 18 in the other three patients with
PHS.
Among the 11 annotated/predicted genes located within
the chromosome 18q21.1–deleted interval, 2 genes were
regarded as strong candidates for PHS—namely, methyl-
CpG–binding domain protein 2 (MBD2 [MIM 603547])7
and transcription factor 4 (TCF4).8,9 The coding sequences
and ﬂanking introns of TCF4 were PCR ampliﬁed and
sequenced by the ﬂuorometric method on both strands
(Big DyeTerminator Cycle Sequencing Kit [Applied Bio-
systems]) (primers and PCR conditions available on re-
quest). Remarkably, we identiﬁed a heterozygous point
mutation at the same arginine 576 codon in all three of
the analyzed subjects. The base change was a CrT tran-
sition at position 1726 leading to the substitution of an
arginine by a tryptophane (R576W) in patients 3 and 4,
whereas a GrA transition at position 1727 led to the sub-
stitution of an arginine by a glutamine (R576Q) in patient
2. In addition, the three base changes occurred de novo,
since they were found neither in the parent DNA nor in
a panel of 338 control chromosomes.
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Table 1. Clinical and Molecular Findings in Patients with PHS
Phenotype
Patient
1 2 3 4
Sex F F M M
Age at diagnosis (years) 4.5 6.5 10 4.5
Birth parameters (percentile):
Weight and length 50th 50th 50th 50th
Occipitofrontal circumference 25th 10th 50th 50th
Growth parameters (percentile):
Height 25th 25th 10th 50th
Weight 25th 25th 10th 25th
Neurologic ﬁndings:
Postnatal microcephaly (percentile) 3rd !2nd 3rd 3rd
Epilepsy (age at onset, in years)   (3.5)  (8)  (4.5)
Hyperventilation (age at onset, in years)   (3.5)  (5)  (4.5)
Stereotypic movements (hands/head) (/) (/) (/) (/)
Genitalia Normal Normal Abnormala Abnormala
Scoliosis Mild   
Hands (small size, SPC, clubbing of ﬁngers) (, , ) (, , ) (, , ) (, , )
Other 3 Nipples Sleeping disorder 3 Nipples 
EEG abnormalities (testing age, in years)  (2)  (3)  (6)  (3)
Brain MRI abnormalities (testing age, in years)  (4.5)  (6.5)  (6.5) Not performed
Results of TCF4 gene screening Del RP11-397A16 R576Q R576W R576W
NOTE.—All patients have severe mental retardation, strabismus, the PHS facial gestalt, and severe chronic constipation
and gastroesophageal reﬂux. A plus sign () indicates presence of a train; a minus sign () indicates absence of a trait;
a double plus sign () indicates that the trait is severe.
a Unilateral cryptorchidism and small penis.
TCF4—also referred to as “ITF-2” (for immunoglobulin
transcription factor 2), “E2-2,” or “SEF2” (for SL3-3 en-
hancer factor 2)—belongs to the class I basic helix-loop-
helix (bHLH) protein family, also known as the “E-protein
family.” Ubiquitously expressed class I bHLHs consist of
TCF4, HEB,10 and the differentially spliced products of the
E2A gene: E12 and E47.11 E proteins contain a common
bHLH structural motif that mediates homo- and hetero-
dimerization between bHLH proteins via their HLH do-
main, whereas the adjacent basic region mediates the
binding of the dimers to a common DNA sequence (CAN-
NTG) known as an “E box.”12 All four members of the
mammalian class I bHLH transcription factors (TFs) are
evolutionarily conserved and play critical roles in cell-
fate determination and differentiation.13 TCF4 is a down-
stream target of the WNT/b-catenin/TCF pathway and,
like cMYC and cyclinD1, has been shown to function as
an oncogene when deregulated.14 Remarkably, the three
TCF4 missense mutations identiﬁed in subjects with PHS
altered the same arginine 576 residue. This amino acid lies
within the basic region of the bHLH domain and is ex-
tremely conserved among bHLH proteins (ﬁg. 3B). More-
over, this residue is known to play an essential role for
DNA recognition, since it stabilizes the glutamic residue
that directly interacts with DNA.15 Interestingly, an en-
gineered missense mutation of the homologous arginine
residue impaired DNA-binding properties but not dimer-
ization in other bHLH proteins, thus resulting in a dom-
inant negative effect (by trapping partners in the homo-
or heterodimeric complex) by inhibition of E box–medi-
ated transcription (E2A and BMAL1).16,17 It is worth noting
that, although PHS is difﬁcult to assess because of the
severity of the handicap and the small number of patients,
patient 1 (harboring the large-scale deletion) is not more
severely affected than the other three patients who harbor
a TCF4 missense mutation. Hence, a contiguous gene syn-
drome is unlikely, and a loss-of-function of at least 50%
is the most likely pathophysiological mechanism under-
lying PHS. This hypothesis is further supported by the
observation that, in mice, embryonic development has
been shown to be sensitive to E-protein copy number,
since the absence of three copies causes embryonic le-
thality.18 Tcf4-null mice were born with a frequency !25%
and subsequently died within the 1st wk of life.18 No mal-
formation has been reported, and the cause of death re-
mains unclear. Conditional Tcf4-deﬁcient mice generated
with the Cre/loxP system exhibit impaired B and T cell
development.19
Despite expression of TCF4 in human embryonic buds,
no congenital malformation has been reported elsewhere
for PHS except for the supernumerary nipple in two sub-
jects (this study) and Hirschsprung disease (HSCR) in one
subject.5 By contrast, TCF4 is also expressed in adult brain,
skeletal muscle, lung, and heart, which is consistent with
the postnatal growth retardation and microcephaly ob-
served in the course of the disease. Similarly, epileptic en-
cephalopathy and bouts of hyperventilation could be as-
cribed to the dysregulation of neurogenic bHLHs that form
heterodimers with TCF4, especially the human Achaete-
Scute homolog 1 (ASCL1 [MIM 100790]).20 Indeed, TCF4
forms a functional complex with the ASCL1.21 Previous
work on cellular and animal models has demonstrated
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Figure 2. Brain MRI ﬁndings for patients with PHS. A, T1-weighted sagittal images. B and C, Coronal ﬂair or T2 sequences. Anomalies
consistently noticed include a thin corpus callosum and moderate hypoplasia of the frontal lobes (A), marked white-matter hyperintensity
in the temporal poles (B), and small hippocampi (C). The brain stem is normal (A). Patient 1, Mild ventricular dilatation and moderate
hyperintensity of the dentate nuclei at age 4.5 years. Patient 2, No ventricular dilatation but moderate hyperintensity of the dentale
nuclei, observed at age 6.5 years. Patient 3, Mild ventricular dilatation and no abnormalities of the posterior fossa at age 6.5 years.
thatmutations affecting the ASCL1–PHOXdevelopmental
pathway impaired the development of neurons of the nor-
adrenergic lineage, resulting in abnormal respiratory net-
work in the brain stem and periphery.22,23 Finally, several
clinical features observed in patients with PHS could also
result from deregulation of TCF4 downstream targets.
Along these lines, it is worth remembering that the re-
spiratory neuron homeobox gene (RNX, also known as
“TLX3” and “HOX11L2” [MIM 604640])24 includes several
E boxes in its 5′ regulating region and that Rnx-deﬁcient
mice display an abnormal respiratory pattern, with alter-
nating tachypnea and apnea.25
An abnormal ventilatory pattern characterized by daily
bouts of diurnal hyperventilation is the hallmark of PHS
but is not reported for patients younger than 3 years. Ep-
ilepsy generally occurs later in the course of the disease,
and 24-h EEG recordings of patient 2 (the present report)
and of case 1 reported by Peippo5 conﬁrmed that the two
features are unrelated. Episodes of hyperventilation occur
only during wakefulness, but, because of themental hand-
icap of the patients, voluntary triggering remains a difﬁ-
cult option to assess. Conversely, these hyperpneic epi-
sodes could be included in the spectrum of dysautonomic
features observed in patients with PHS. Indeed, dilated
pupils with sluggish response to light have been noticed.
Finally, one patient had short-segment HSCR, a congenital
malformation of the enteric nervous system (case 2 re-
ported by Peippo5), and other patients have severe gastro-
intestinal dysfunction. The identiﬁcation of TCF4 as the
disease-causing gene in PHS may bring new insight into
normal autonomic nervous systemdevelopment andmain-
tenance of appropriate ventilation.
The association of HSCR (or severe constipation) with
severe mental retardation also points to Mowat-Wilson
(MIM 235730) and Goldberg-Shprintzen (MIM 609460)
syndromes as differential diagnoses. Similarly, the occur-
rence of hyperventilation frequently also raises the issue
of Rett syndrome (MIM 312750) in female patients with
PHS. Yet, in addition to distinctive facial features, all pa-
tients with PHS reported to date had abnormal psycho-
motor development from the neonatal period. Although
progressive, the disease does not have a regressive course
after a period of near-normal development. Conversely,
neither loss of purposeful hand movements nor severe
progressive scoliosis is reported in PHS. Angelman syn-
drome (MIM 105830) is also invariably discussed and
tested, although the facial gestalt and EEG ﬁndings clearly
differ between the two conditions.
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Figure 3. Genetic analyses of patients with PHS. A, Chromosome 18 array-CGH ratio proﬁle obtained for patient 1 that identiﬁes
deletion of a single clone at chromosome 18q21.1. The X-axis represents the distance, in base pairs, along the chromosome from the
p telomere. The Y-axis represents the hybridization ratio (reference DNA vs. test DNA) plotted on a log2 scale. Gray lines indicate
thresholds for clone deletion or duplication (array ratio mean4 SD). The ﬁgure also shows the Ensembl display of this region. B, TCF4
gene mutations and phylogenetic analysis of TCF4 proteins. The two de novo missense mutations (R276Q and R276W) identiﬁed in
patients 2–4 are shown. ClustalW (National Center for Biotechnology Information) alignment of class I bHLH proteins orthologs are
shown. Shadowed amino acids correspond to conserved glutamic and arginine residues constituting the E box–recognition motif.
In conclusion, on the basis of the facial gestalt, PHS
should be regarded as a clinically recognizable entity, even
before the occurrence of hyperventilation and epilepsy.
Electrophysiologic ﬁndings and brain MRI should be of
valuable help at that time. We believe that the syndrome
will now be recognized with a greater frequency than was
initially expected, and we suggest that TCF4-mutation
screening be recommended for patients for whom over-
lapping syndromes were unsuccessfully tested—namely,
Angelman, Rett, and Mowat-Wilson syndromes.
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